Remedies for Breach of Certain Study Obligations Sample Clauses

Remedies for Breach of Certain Study Obligations. In the event Principal Investigator or Institution fails to comply with any of its obligations set out in Sections 3 (Protocol), 7 (Informed Consent and Subject Recruitment), 11 (Study Data, Biological Samples, and Study Records) and 12 (Monitoring, Inspections, and Audits) of this Agreement, or the requirements of the Protocol relating to adverse event reporting, ethical conduct of 13. Nápravné prostředky v případě porušení určitých závazků Studie. V případě, že Hlavní zkoušející nebo zdravotnické zařízení nesplní některý ze svých závazků stanovených v článcích 3 (Protokol), 7 (Informovaný souhlas a nábor subjektů), 11 (Studijní údaje, biologické vzorky a studijní záznamy) a 12 (Monitorování, inspekce a audity) této Smlouvy nebo požadavků Protokolu týkajících se hlášení nežádoucích příhod, etického provádění the Study, and SUKL/relevant IRB/IEC review, in addition to its right to terminate the Study immediately under Section 18.1.c(2), CRO will have recourse to either or both of the following alternative remedies: Studie a kontroly ze strany SÚKL/EK, bude se CRO, kromě svého práva Studii okamžitě ukončit podle článku 18.1.c(2), moci uchýlit k jednomu nebo oběma z následujících nápravných prostředků:
AutoNDA by SimpleDocs
Remedies for Breach of Certain Study Obligations. In the event Institution fails to comply with any of its obligations set out in Sections 3 (Protocol), 7 (Informed Consent and Subject Recruitment), 11 (Study Data, Biological Samples, and Study Records) and 12 (Monitoring, Inspections, and Audits) of this Agreement, or the requirements of the Protocol relating to adverse event reporting, ethical conduct of the Study, and SUKL/relevant IEC review, the following will apply. In addition to its right to terminate the Study immediately under Section 18.1.c(2), CRO will have recourse to either or both of the following alternative remedies: 13. Nápravné prostředky v případě porušení určitých závazků Studie. V případě, že Instituce nesplní některý ze svých závazků stanovených v článcích 3 (Protokol), 7 (Informovaný souhlas a nábor subjektů), 11 (Studijní údaje, biologické vzorky a záznamy o studii) a 12 (Monitorování, inspekce a audity) této Smlouvy nebo požadavků Protokolu týkajících se hlášení nežádoucích příhod, etického provádění Studie a kontroly ze strany SÚKL/příslušné EK, uplatní se následující postup. CRO, vedle svého práva Studii okamžitě ukončit podle článku 18.1.c (2), se bude moci uchýlit k jednomu nebo oběma z následujících nápravných prostředků: a. Suspension of Study Subject enrollment, if the Study is not yet fully enrolled, and a. pozastavení náboru subjektů Studie, jestliže nábor do Studie není ještě ukončen, a b. Suspension of payment to Institution and b. pozastavení plateb Instituci a Hlavnímu zkoušejícímu. Principal Investigator Any suspension of enrollment or payment will continue until Institution and Principal Investigator return to compliance with their Study obligations, as determined by CRO. Use of either or both of the above remedies does not preclude CRO or Pfizer from exercising its right to immediately terminate the Study if Institution and Principal Investigator do not both become compliant. Jakékoli pozastavení náboru nebo plateb bude pokračovat do té doby, dokud Instituce a Hlavní zkoušející podle zjištění CRO neobnoví dodržování svých závazků ze Studie. Použití jednoho nebo obou nápravných prostředků nebrání CRO nebo společnosti Pfizer v uplatnění jejího práva okamžitě ukončit Smlouvu, jestliže Instituce i Hlavní zkoušející nezačnou dodržovat závazky. 14.
Remedies for Breach of Certain Study Obligations. In the event Principal Investigator or Institute fails to comply with any of its obligations set out in Sections 3 (Protocol), 7 (Informed Consent and Subject Recruitment), 11 (Study Data, Biological Samples, and Study Records) and 12 (Monitoring, Inspections, and Audits) of this Agreement, or the requirements of the Protocol relating to adverse event reporting, ethical conduct of the Study, and SUKL/relevant Ethics Committee, review, in addition to its right to terminate the Study a.
Remedies for Breach of Certain Study Obligations. In the event Institution fails to comply with any of its obligations set out in Sections 3 (Protocol), 7 (Informed Consent and Subject Recruitment), 11 (Study Data, Biological Samples, and Study Records) and 12 (Monitoring, Inspections, and Audits) of this Agreement, or the requirements of the Protocol relating to adverse event reporting, ethical conduct of the Study, and SUKL/relevant IEC review, or Principal Investigator fails to comply with any of his/her comparable obligations in the agreement between CRO and Principal Investigator, the following will apply. In addition to its right to terminate the Study immediately under Section 18.1.c(2), CRO will have recourse to either or both of the following alternative remedies:
Remedies for Breach of Certain Study Obligations. In the event Principal Investigator or Institution fails to comply with any of its obligations set out in Sections 3 (Protocol), 7 (Informed Consent and Subject Recruitment), 11 (Study Data, Biological Samples, and Study Records) and 12 (Monitoring, Inspections, and Audits) of this Agreement, or the requirements of the Protocol relating to adverse event reporting, ethical conduct of the Study, and SUKL/relevant IRB/IEC review, in addition to its right to terminate the Study immediately under Section 18.1.c(2), CRO will have recourse to either or both of the following alternative remedies: 13. Nápravné prostředky v případě porušení určitých závazků Studie. V případě, že Hlavní zkoušející nebo Instituce nesplní některý ze svých závazků stanovených v článcích 3 (Protokol), 7 (Informovaný souhlas a nábor subjektů), 11 (Studijní údaje, biologické vzorky a studijní záznamy) a 12 (Monitorování, inspekce a audity) této Smlouvy nebo požadavků Protokolu týkajících se hlášení nežádoucích příhod, etického provádění Studie a kontroly ze strany SÚKL/EK, bude se CRO, kromě svého práva Studii okamžitě ukončit podle článku 18.1.c(2), moci uchýlit k jednomu nebo oběma z následujících nápravných prostředků:
Remedies for Breach of Certain Study Obligations. In the event Principal Investigator or Provider fails to comply with any of its obligations set out in Sections 3 (Protocol), 7 (Informed Consent and Subject Recruitment), 11 (Study Data, Biological Samples, and Study Records) and 12 (Monitoring, Inspections, and Audits) of this Agreement, or the requirements of the Protocol relating to adverse event reporting, ethical conduct of the Study, and SUKL/relevant Ethics Committee, review, in addition to its right to terminate the Study immediately under Section 18.1.c(2), CRO will have recourse to either or both of the following alternative remedies:
Remedies for Breach of Certain Study Obligations. If Institution fails to comply, for any Study, with any of its obligations set out in Sections 4 (Protocol), 8 (HIPAA Authorization, Informed Consent, and Subject Recruitment), 12 (Study Data, Biological Samples, and Study Records) and 13 (Monitoring, Inspections, and Audits) of this Master Agreement, or the requirements of the Protocol relating to adverse event reporting, ethical conduct of the study, and IRB review, in addition to its right to terminate the Study immediately under Section 20.5, Pfizer will have recourse to either or both of the following alternative remedies:
AutoNDA by SimpleDocs

Related to Remedies for Breach of Certain Study Obligations

  • REMEDIES FOR BREACH It is understood and agreed that all rights and remedies afforded below shall be in addition to all remedies or actions otherwise authorized or permitted by law:

  • Liability for Breach of Contract 1. Any Party who violates the provisions of this Agreement and makes all or part of this Agreement unenforceable, shall be liable for breach of contract and shall compensate the other Party for the losses caused thereby (including the litigation fees and attorney fees caused thereby). If both Parties breach this Agreement, each shall bear the corresponding responsibility according to the actual situations.

  • Remedies for Contractor Breach Pertaining to contract-related issues, it is the responsibility of both the Agency and the Contractor to communicate with each in as clear and complete a manner as possible. If at any time during the term of this contract the Agency or the Contractor is not satisfied with any issue, it is the responsibility of that party to deliver to the other party communication, in writing, fully detailing the issue and corrective action (please note that the Agency has the right to issue unilateral addendums to this contract, but the Contractor does not have the same right). The other party shall, within 10 days, respond in writing to the other party (however, the Agency shall retain the right to, if conditions warrant, require the Contractor to respond in a shorter period of time). Further, the Agency shall, at a minimum, employ the following steps in dealing with the Contractor as to any performance issues:

Time is Money Join Law Insider Premium to draft better contracts faster.